UK and international labs can enroll in this EQA program (code POCT CYP2C19) via EMQN CIC at https://www.emqn.org/our-eqa-schemes/ and enquiries about Microbix QAPs can be directed to customer.service ...
Part A results demonstrated efficacy and safety; ATSN-201 on track to be first gene therapy and one-time treatment for XLRS DURHAM, N.C., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company developing AI-powered, incision-free therapies for ablating diseased tissue, anno ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback